Moderna’s COVID/influenza combination vaccine outperforms some vaccines in trials

Moderna said Monday that its combination vaccine to protect against both COVID-19 and influenza elicited a stronger immune response in adults aged 50 and older compared with separate vaccinations against the viruses in a late-stage study.

Share This Post: